1. CRISPR therapeutics and vertex announce positive safety and efficacy data from first two patients treated with investigational CRISPR/Cas9 gene-editing therapy CTX001® for severe hemoglobinopathies [Internet]. Boston: Vertex Pharmaceuticals; 2019 Nov 19 [cited 2020 May 9]. Available from: https://investors.vrtx.com/node/27071/pd.
2. Stein R. Gene-edited ‘supercells’ make progress in fight against sickle cell disease [Internet]. Washington, DC: National Public Radio; 2019 Nov 19 [cited 2020 May 9]. Available from: https://www.npr.org/sections/health-shots/2019/11/19/780510277/gene-edited-supercells-make-progress-in-fight-against-sickle-cell-disease.
3. The CRISPR craze;Pennisi;Science,2013
4. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product;Ishino;J Bacteriol,1987
5. Molteni M. Everything you need to know about CRISPR gene editing [Internet]. San Francisco: Wired; 2017 Dec 5 [cited 2020 May 9]. Available from: https://www.wired.com/story/what-is-crispr-gene-editing/.